Position in ILMN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,934
+$579 QoQ
Shares Held
11
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#879
of 932 holders
Holding Since
Dec 2021
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JNBA Financial Advisors holds $400,845 across 10 Diagnostics & Research names. ILMN ranks #9 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
1,141 | $171,184 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
185 | $92,751 | |
| 3 | A |
Agilent Technologies, Inc.
|
608 | $80,760 | |
| 4 | DHR |
Danaher Corp /De/
|
109 | $20,762 | |
| 5 | WAT |
Waters Corp /De/
|
35 | $13,126 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
23 | $12,180 | |
| 7 | DGX |
Quest Diagnostics Inc
|
26 | $5,510 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
5 | $2,632 |
All Filings in ILMN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,934 | 11 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,355 | 11 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,442 | 11 | Shares | Sole | 2026-01-26 | |
| 2023-12-31 | $417 | 3 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $411 | 3 | Shares | Sole | 2023-11-02 | |
| 2021-12-31 | $3,804 | 10 | Shares | Sole | 2022-02-03 | |
| No filing history on record for this holder in this stock. | ||||||